Want to create an interactive transcript for this episode?
Podcast: PeerView Clinical Pharmacology CME/CNE/CPE Video
Episode: Gail J. Roboz, MD - Maintaining “Intensity” for Better Outcomes in AML: Guidance on Modern, Intensive Upfront Platforms in Challenging Patient Populations
Description: Go online to PeerView.com/BMM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Robust clinical evidence has proven that more effective upfront treatment platforms based on novel cytotoxics and targeted agents are now available for acute myeloid leukemia (AML)—including for difficult-to-treat subtypes (eg, secondary AML, mutation-defined disease). These new options have been shown to extend survival and, importantly, to allow more patients to reach hematopoietic stem cell transplant (HCT), a potentially curative treatment. Is a new ‘intensive’ treatment strategy forming in the context of modern AML care? Find out in this a...